The nutrition industry continues to move quickly, driven by new science, changing consumer priorities and a growing demand for ingredients that can deliver both meaningful differentiation and credible clinical support. At SupplySide Global 2026, Maypro will showcase a strong pipeline of new branded ingredients, newly published and emerging clinical research, and formulation technologies spanning women’s health, the microbiome, cognitive health, mood and sleep, active nutrition and functional beverages. Many of these innovations reflect where we see the market moving into 2027: more targeted science, greater attention to healthspan and life-stage nutrition, new microbiome and peptide technologies, and ingredient formats designed to move beyond the traditional capsule. Visit Maypro at Booth #5836 and see what’s next. Aspurūs® is a standardized, full-spectrum Shatavari root extract developed for women’s health across key life stages. Standardized to 5% total Shatavarins and produced through a proprietary soft-extraction process, Aspurūs® is supported by three published human clinical studies to date, with several additional studies underway. A recent recipient of multiple industry awards recognizing innovation in women’s health and ESG leadership, Aspurūs® brings strong science, sustainability and differentiation to the rapidly evolving women’s health market. PeptiDRIVE-LNDP™ is a novel milk-derived bioactive peptide developed for cognitive performance, including memory, processing speed and executive function. Its fast-acting profile creates new formulation opportunities for brain health, mental performance and healthy aging. LAC-Living+™ is a clinically studied postbiotic derived from heat-treated Lactobacillus helveticus, offering formulators a differentiated microbiome-based approach to supporting positive mood and emotional well-being. vitalGABA® is a highly concentrated GABA ingredient produced from fermented barley and plant-derived glutamic acid. At a low daily dose, its human research spans restorative sleep, mood and daytime vitality, with additional research supporting muscle function and healthy aging. CordyFuel™ 10X brings a new approach to stimulant-free energy and active nutrition. This concentrated Cordyceps militaris ingredient is standardized to 3 mg/g cordycepin, providing a defined bioactive marker for formulations targeting sustained energy, stamina and physical performance. Women’s Metabolic & Hormonal Health New 12-week clinical research with the postbiotic form of AKK PROBIO expands the potential of Akkermansia muciniphila into women’s metabolic and hormonal health. Perimenopause Support A newly published 2026 randomized, double-blind, placebo-controlled clinical trial evaluated Aspurūs® at 500 mg/day in 150 perimenopausal women over 12 weeks. The study assessed far more than hot flashes, examining the multidimensional experience of perimenopause across vasomotor, psychological, cognitive, sleep, stress, fatigue, sexual health and quality-of-life measures. Aspurūs® produced significant improvements in overall perimenopausal symptom frequency and intensity, with additional improvements across hot flashes, sleep, stress, fatigue, cognitive symptoms, sexual well-being and menopause-specific quality of life. The study was published online July 31, 2026 in the Journal of Dietary Supplements. Gut-Immune Axis Support CLB101™, ClostraBio’s Anaerostipes caccae probiotic, takes a differentiated approach to microbiome support by directly producing butyrate in the lower gut. Its first randomized, double-blind, placebo-controlled human clinical study has now produced positive topline results, with publication expected in September. Watch for the full clinical findings in an upcoming Maypro communication. Endurance and Exertion New human clinical research adds to the extensive science behind Oligonol®, demonstrating improvements in endurance performance together with reductions in perceived exertion, expanding its relevance for active nutrition, performance and healthy aging formulations. Blood Flow, Performance and Body Composition New clinical research published in the Journal of Exercise and Nutrition found that daily VasoDrive-AP® supplementation supported improvements in body composition and enhanced muscle blood flow following exercise, adding to its established positioning in cardiovascular and active nutrition. Cognitive Performance New human research continues to build the science behind PeptiDRIVE-LNDP™ and its role in cognitive performance. When taken 30 minutes before cognitive testing, PeptiDRIVE-LNDP supplementation improved aspects of cognitive function in healthy adults, including verbal memory, composite memory, processing speed and executive function. Mood, Stress, and Sleep Support A new 56-day placebo-controlled clinical trial expands the science behind SaffonX+™, Maypro’s standardized high-purity saffron extract. Supplementation significantly improved measures of mood and emotional well-being, sleep quality and stress, supporting SaffonX+™ as a multi-benefit botanical for the rapidly expanding mental wellness market. FDA NDI Notification AKK PROBIO postbiotic has reached an important U.S. regulatory milestone with an FDA-acknowledged New Dietary Ingredient notification, further strengthening its path to commercialization in the U.S. dietary supplement market. New Liquid Full-Spectrum Mushroom Technology NuCelium™ Liquid Full-Spectrum Technology brings functional mushrooms into modern beverage applications. Its proprietary encapsulation technology preserves the full-spectrum fungal matrix while improving suspension, dispersibility and mouthfeel, creating new opportunities for functional beverages, shots and other liquid formats. From new clinical research in women’s health and the microbiome to emerging peptide science, active nutrition and advanced formulation technologies, Maypro is bringing a broad pipeline of innovation to SupplySide Global. Come talk with our team about what fits your pipeline and what we see coming next for 2027.
Launching at SupplySide Global

Women’s Health
Cognitive Health
LAC-Living+™
Mood & Emotional Well-Being
Sleep, Vitality & Healthy Aging
CordyFuel™ 10X
Caffeine-Free Energy & Performance
New Clinical Research

Compared with placebo, supplementation was associated with significant improvements in body weight, BMI, insulin resistance and metabolic markers, along with improvements in testosterone, LH, the LH/FSH ratio and menstrual cycle regularity. Researchers also observed meaningful changes in the gut microbiota, including increased microbial diversity and enrichment of potentially beneficial taxa including Bifidobacterium and Faecalibacterium. This research opens an important new chapter for Akkermansia at the intersection of the microbiome, metabolic health and women’s health.




Research surrounding LNDP also points to neurotrophic pathways associated with BDNF, NGF and other signaling systems involved in learning, memory and neuronal function.
Portfolio & Technology Milestones


See What’s Next at Booth #5836


